Posted in

Toxic Cough Syrup Scandal: Key Figures in Custody

•Posted inMedical Updates
Doctor studying blended paediatric fellowship programme with online learning and paediatric clinical training modules.

The provided blog post discusses a serious incident involving contaminated cough syrup and the resulting deaths of children. It highlights issues in drug regulation, manufacturing, and distribution.

Here’s the updated HTML with relevant internal links integrated:

Recent developments in the ongoing investigation into fatal cough syrup deaths have seen the owner of a Tamil Nadu-based pharmaceutical firm remanded in judicial custody. Ranganathan Govindan, proprietor of Sresen Pharma, manufactured the contaminated ‘Coldrif’ syrup. This medicine is tragically linked to the deaths of more than 20 children in Madhya Pradesh. A local court in Chhindwara issued the remand order on Monday.

Judicial Remand for Sresen Pharma Owner

A Special Investigation Team (SIT) previously questioned Govindan in Kanchipuram, Tamil Nadu. He was held in police custody for ten days. After this period, authorities produced him before Additional Session Judge Gautam Gurjar in Parasia town. Therefore, the court ordered his judicial custody.

The ‘Coldrif’ syrup contained diethylene glycol (DEG), a highly toxic industrial solvent. Investigations revealed DEG concentrations far exceeding permissible limits, sometimes reaching nearly 49%. This dangerous contamination caused acute kidney failure in children. Tragically, at least 24 children from Chhindwara and neighboring districts succumbed to its effects.

Key Figures in Custody and Regulatory Actions

Alongside Govindan, several other individuals are also in judicial custody. Dr. Praveen Soni, a Chhindwara-based doctor who prescribed the toxic syrup, is among them. His nephew Rajesh Soni, a medicine wholesaler, is also held. Saurabh Jain, a pharmacist at a medical store owned by Dr. Soni’s wife, is similarly in custody.

Earlier, a local court rejected Dr. Soni’s bail plea. He subsequently moved the Madhya Pradesh High Court. Furthermore, authorities have sealed Sresen Pharma’s manufacturing unit. The state government also took swift action. It suspended two drug inspectors and a deputy director of the Food and Drug Administration (FDA). Moreover, the state’s drug controller was transferred following these devastating deaths. The Tamil Nadu government has also revoked Sresen Pharma’s manufacturing license. This action led to its permanent shutdown.

Broader Implications of Contaminated Cough Syrup Deaths

This incident highlights persistent issues within India’s drug regulatory system. Similar tragedies involving contaminated cough syrups have occurred in the past, both domestically and internationally. For example, in 2022-23, Indian-manufactured cough syrups were linked to child deaths. These incidents occurred in The Gambia and Uzbekistan. The World Health Organization (WHO) has issued multiple warnings regarding DEG-contaminated syrups.

In response to the crisis, the Drugs Controller General of India (DCGI) mandated stringent testing for diethylene glycol (DEG) and ethylene glycol (EG). This applies to all raw materials and finished oral liquid formulations. This measure aims to close critical regulatory loopholes. The Union Health Ministry also advised against prescribing cough-cold medications to children under two years old. Additionally, new Schedule M norms and updated Good Manufacturing Practice (GMP) standards are being enforced.

Frequently Asked Questions

Q1: Who is Ranganathan Govindan and what is his role in the Coldrif syrup case?

Ranganathan Govindan is the owner of Sresen Pharma, the Tamil Nadu-based company that manufactured the contaminated ‘Coldrif’ cough syrup linked to the deaths of over 20 children in Madhya Pradesh. He has been remanded in judicial custody.

Q2: What toxic substance was found in the ‘Coldrif’ cough syrup?

Investigations confirmed that the ‘Coldrif’ cough syrup contained dangerously high levels of diethylene glycol (DEG), an industrial solvent. This chemical caused acute kidney failure in the affected children.

Q3: What actions have regulatory bodies taken in response to these cough syrup deaths?

Regulatory actions include the sealing of Sresen Pharma’s manufacturing unit, suspension of drug inspectors and a deputy director of the FDA, transfer of the state’s drug controller, and the permanent revocation of Sresen Pharma’s manufacturing license. Furthermore, the DCGI mandated stricter testing for DEG and EG in all oral liquid formulations. This increased scrutiny highlights the importance of robust safe prescribing practices and stringent quality control in pharmaceutical manufacturing.

References

  1. Cough syrup deaths: MP court remands TN-based firm owner in judicial custody – ETHealthworld
  2. Toxic Cough Syrup, Weak Oversight: India’s Unending Drug Safety Crisis – Google Vertex AI Search
  3. Cough Syrup Deaths in India: Understanding the Contamination Crisis and Regulatory Response – Vision IAS
  4. WHO raises alert over DEG-contaminated cough syrups in India – RAPS
  5. Drugmakers in India warned as toxic cough syrup linked to deaths of 24 children – Sky News
  6. 2025 India cough syrup crisis – Wikipedia
  7. Sresan Pharma Owner G Ranganathan Arrested In Chennai Over Coldrif Cough Syrup Deaths | News – Times of India Videos
  8. Contaminated cough syrup linked to deaths of 14 children in India – The BMJ
  9. Cough syrup tragedy: Madhya Pradesh bans Coldrif as kids’ death toll rises to 11; test report confirms poisonous chemical – Times of India
  10. Contaminated Cough syrup tragedy: Sresen Pharma owner remanded in 10-day police custody – Medical Dialogues
  11. “India’s Regulatory Landscape for Cough Syrups: CDSCO / DCGI Requirements, Legal References & Recent Cases”. | TaxTMI
  12. Cough Syrup Deaths: After Madhya Pradesh, West Bengal Bans ‘Coldrif’ – India Today
  13. Killer Cough Syrup Scandal: Sresan Pharma Owner Arrested | Coldrif Contaminated – India Today
  14. Cough syrup deaths: Here are 5 key revelations in Coldrif case – The Indian Express
  15. Coldrif cough syrup maker shut permanently over child deaths, owner arrested – India Today
  16. Cough syrup deaths: Tamil Nadu suspends 2 drug inspectors, moves to close pharma co – Times of India
  17. Drug regulator tightens safety norms after cough syrup deaths – Times of India
  18. Why do children keep dying from toxic cough syrup? | TBIJ

Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.